Staff Writer Biotheranostics (San Diego), a specialist in the molecular diagnostics for cancer market, said it raised $32 million and will be spun out from Biomérieux SA (Marcy-l'Étoile, France). The financing was led by MVM Life Science Partners, with participation of Canepa Advanced Healthcare Fund and Healthquest Capital.